| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,808,296 | 1,063,015 | 499,258 | 915,761 | | Cost of Revenue | 1,470,674 | 842,558 | 376,165 | 735,229 | | | Gross Profit | 337,622 | 220,457 | 123,093 | 180,532 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 180,294 | 168,990 | 164,379 | 177,360 | | Non Recurring | 8,766 | 18,017 | (268) | 271,809 | | Others | 37,401 | 36,885 | 43,413 | 48,706 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 114,819 | (3,435) | (84,431) | (317,343) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,800 | 1,675 | (613) | 976 | | Earnings Before Interest And Taxes | 113,460 | (852) | (84,469) | (316,684) | | Interest Expense | 17,438 | 15,951 | 17,313 | 17,377 | | Income Before Tax | 96,022 | (16,803) | (101,782) | (334,061) | | Income Tax Expense | 16,850 | 10,005 | 1,375 | 15,894 | | Minority Interest | (9,925) | 60 |
-
| (1,710) | | | | Net Income From Continuing Ops | 79,112 | (26,748) | (103,157) | (349,955) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 12,429 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 69,247 | (26,748) | (103,157) | (337,526) | | Preferred Stock And Other Adjustments |
-
| (450) | 450 |
-
| | | Net Income Applicable To Common Shares | $69,247 | ($27,198) | ($102,707) | ($337,526) |
|
0.20% Nasdaq 
Income Statement
